Literature DB >> 21915771

Bone radiofrequency ablation combined with prophylactic internal fixation for metastatic bone tumor of the femur from hepatocellular carcinoma.

Koichi Ogura1, Ryoko Miyake, Shuichiro Shiina, Yusuke Shinoda, Tomotake Okuma, Hiroshi Kobayashi, Takahiro Goto, Kozo Nakamura, Hirotaka Kawano.   

Abstract

A 64-year-old man with 6-year history of hepatocellular carcinoma (HCC) was referred to us regarding bone metastasis to the right proximal femur. Although he underwent radiotherapy for pain palliation and local tumor control, the pain persisted and the tumor relapsed 3 months after the radiotherapy and he was thought to be at high risk of pathologic fracture. Given hypervascularity and large tumor size, a prophylactic internal fixation combined with adjuvant radiofrequency ablation (RFA) was proposed to reduce blood loss and prevent viable tumor cells being disseminated. His postoperative course was uneventful without requiring blood transfusion and preoperative symptoms immediately disappeared after surgery. He became capable of weight-bearing walk with a single cane and was almost asymptomatic without local progression on the plain radiographs when he died 14 months after surgery. Combination therapy of RFA and internal fixation using intramedullary nailing for metastases of the long bones from HCC seems to be a very promising technique both for sufficient pain relief and for local control of the tumor. Adjuvant RFA may become a potential option for patients with metastases of the long bones for the purpose of prevention of tumor dissemination and reduction of intraoperative blood loss.

Entities:  

Mesh:

Year:  2011        PMID: 21915771     DOI: 10.1007/s10147-011-0319-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  20 in total

1.  Clinical assessment of percutaneous radiofrequency ablation for painful metastatic bone tumors.

Authors:  Hiroyuki Kojima; Noboru Tanigawa; Shuji Kariya; Atsushi Komemushi; Yuzo Shomura; Satoshi Sawada
Journal:  Cardiovasc Intervent Radiol       Date:  2006 Nov-Dec       Impact factor: 2.740

2.  Image-guided radiofrequency ablation of spinal tumors: preliminary experience with an expandable array electrode.

Authors:  Dietrich H W Grönemeyer; Sven Schirp; Athour Gevargez
Journal:  Cancer J       Date:  2002 Jan-Feb       Impact factor: 3.360

3.  Combined treatment of ablative therapy with percutaneous radiofrequency and cementoplasty of a symptomatic metastatic lesion of the acetabulum.

Authors:  G Carrafiello; D Laganà; C Recaldini; M Mangini; A Giorgianni; S Cuffari; G Dionigi; F D'Angelo; C Fugazzola
Journal:  Australas Radiol       Date:  2007-12

4.  Percutaneous radiofrequency ablation of painful spinal tumors adjacent to the spinal cord with real-time monitoring of spinal canal temperature: a prospective study.

Authors:  Atsuhiro Nakatsuka; Koichiro Yamakado; Haruyuki Takaki; Junji Uraki; Masashi Makita; Fumiyoshi Oshima; Kan Takeda
Journal:  Cardiovasc Intervent Radiol       Date:  2008-07-26       Impact factor: 2.740

5.  Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients.

Authors:  T Kaizu; K Karasawa; Y Tanaka; T Matuda; H Kurosaki; S Tanaka; T Kumazaki
Journal:  Am J Gastroenterol       Date:  1998-11       Impact factor: 10.864

6.  Pathology of hepatocellular carcinoma in Japan. 232 Consecutive cases autopsied in ten years.

Authors:  T Nakashima; K Okuda; M Kojiro; A Jimi; R Yamaguchi; K Sakamoto; T Ikari
Journal:  Cancer       Date:  1983-03-01       Impact factor: 6.860

7.  Radiofrequency ablation in combination with osteoplasty in the treatment of painful metastatic bone disease.

Authors:  Ralf Thorsten Hoffmann; Tobias F Jakobs; Christoph Trumm; Christof Weber; Thomas K Helmberger; Maximilian F Reiser
Journal:  J Vasc Interv Radiol       Date:  2008-03       Impact factor: 3.464

Review 8.  Radiation for bone metastases: conventional techniques and the role of systemic radiopharmaceuticals.

Authors:  N A Janjan
Journal:  Cancer       Date:  1997-10-15       Impact factor: 6.860

9.  Painful metastases involving bone: feasibility of percutaneous CT- and US-guided radio-frequency ablation.

Authors:  Matthew R Callstrom; J William Charboneau; Matthew P Goetz; Joseph Rubin; Gilbert Y Wong; Jeff A Sloan; Paul J Novotny; Bradley D Lewis; Timothy J Welch; Michael A Farrell; Timothy P Maus; Robert A Lee; Carl C Reading; Ivy A Petersen; Deitra D Pickett
Journal:  Radiology       Date:  2002-07       Impact factor: 11.105

10.  Efficacy of percutaneous cementoplasty for bone metastasis from hepatocellular carcinoma.

Authors:  Hideaki Kodama; Hiroshi Aikata; Kiminori Uka; Shintaro Takaki; Nami Mori; Koji Waki; Soo Cheol Jeong; Yoshiiku Kawakami; Hiroo Shirakawa; Shoichi Takahashi; Naoyuki Toyota; Katsuhide Ito; Kazuaki Chayama
Journal:  Oncology       Date:  2008-01-11       Impact factor: 2.935

View more
  2 in total

1.  Current management of patients with hepatocellular carcinoma.

Authors:  Tatsuo Kanda; Sadahisa Ogasawara; Tetsuhiro Chiba; Yuki Haga; Masao Omata; Osamu Yokosuka
Journal:  World J Hepatol       Date:  2015-07-28

2.  The IlluminOss® photodynamic bone stabilization system for pathological osteolyses and fractures of the humerus: indications, advantages and limits in a series of 12 patients at 24 months of minimum follow-up.

Authors:  Carmine Zoccali; Dario Attala; Mattia Pugliese; Alessandra Scotto di Uccio; Jacopo Baldi
Journal:  BMC Musculoskelet Disord       Date:  2021-01-11       Impact factor: 2.362

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.